XML 41 R15.htm IDEA: XBRL DOCUMENT v3.6.0.2
Fair Value Measurements And Derivative Instruments
12 Months Ended
Dec. 31, 2016
Fair Value Measurements And Derivative Instruments [Abstract]  
Fair Value Measurements And Derivative Instruments

NOTE 8: FAIR VALUE MEASUREMENTS AND DERIVATIVE INSTRUMENTS



Our determination of fair value measurements is based on the assumptions that market participants would use in pricing the asset or liability. At December 31, 2016, the Company’s convertible debt (see Note 7) and certain derivative instruments were the only financial instruments measured in the financial statements at fair value on a recurring basis.  Nonrecurring fair value measurements were utilized in the determination of the fair value of acquired hotel properties and related assumed debt in 2016 and 2015 (see Note 3), the acquisition accounting performed by the Atlanta JV in 2016 (see Note 5), the accounting for the equity transactions that occurred in March 2016 (see Note 10), and in the valuation of impaired hotels during the years ended December 31, 2016, 2015, and 2014.



Derivative Instruments



Currently, the Company uses derivatives, such as interest rate swaps and caps, to manage its interest rate risk.  The fair value of interest rate positions is determined using the standard market methodology of netting the discounted expected future cash receipts and payments. Variable interest rates used in the calculation of projected receipts and payments on the positions are based on an expectation of future interest rates derived from observable market interest rate curves and volatilities.  Derivatives expose the Company to credit risk in the event of non-performance by the counterparties under the terms of the agreements.  The Company believes it minimizes this credit risk by transacting with major creditworthy financial institutions.  These interest rate positions at December 31, 2016 and 2015 are as follows:







 

 

 

 

 

 

 

 

 

 

 

 

 

 

Associated debt

 

Type

 

Terms

 

Effective Date

 

Maturity Date

 

Notional amount at December  31, 2016

 

Notional amount at December  31, 2015

Huntington

 

Swap

 

Swaps 30-day LIBOR +  2.25% for fixed rate of

 

11/2015

 

11/2020

 

$

7,361 (1)

 

$

9,981 (1)



 

 

 

 4.13 %; cancellable at Company's option anytime

 

 

 

 

 

 

 

 

 

 



 

 

 

after 11/01/2018 without penalty

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

Latitude

 

Cap

 

Caps 30-day LIBOR at 1.0%

 

03/2016

 

06/2017

 

$

11,124 (1)

 

$

 -



 

 

 

 

 

 

 

 

 

 

 

 

 

 

Latitude

 

Cap

 

Caps 30-day LIBOR at 2.5%

 

10/2015

 

05/2016

 

$

 -

 

$

11,220 (1)



(1)

Notional amounts amortize consistently with the principal amortization of the associated loans



Additionally, prior to the execution of the Exchange Agreement (see Note 10) on March 16, 2016 which extinguished the instrument, the Company was required to bifurcate and include on the balance sheet at fair value the embedded conversion option in the 6.25% Series C Cumulative Convertible Preferred Stock (“Series C Preferred Stock”) due to the presence of an antidilution provision that required an adjustment in the common stock conversion ratio should subsequent issuances of the Company’s common stock be issued below the instrument’s original conversion price of $52.00 per share.    As a result of a subscription rights offering by the Company which concluded on June 6, 2014 (see Note 9), the conversion price of the Series C Preferred Stock, pursuant to its terms, was adjusted to $10.40, the exercise price of the subscription rights for a share of common stock, where the conversion price remained until the instrument’s extinguishment.



Similarly, prior to the execution of the Exchange Agreement, the terms of the common stock warrants issued to the holders of the Series C Preferred Stock (see Note 10) also included an antidilution provision that required a reduction in the warrant’s exercise price of $62.40 should the conversion ratio of the Series C Preferred Stock be adjusted due to antidilution provisions. Accordingly, the warrants did not qualify for equity classification, and, as a result, the fair value of the derivative was shown as a derivative liability on the balance sheet. As a result of a subscription rights offering by the Company which concluded on June 6, 2014 (see Note 9), the exercise price of the warrants for a share of common stock was adjusted to $12.48, equal to 120% of the adjusted conversion price of the Series C Preferred Stock. With the execution of the Exchange Agreement, this provision of these warrants was effectively eliminated and the conversion price was locked permanently at $12.48.  Following this modification of terms, the warrants qualify for equity classification and were reclassified to additional paid-in capital at their fair value of $611 on the date of the modification.



The fair value of the derivative liabilities recognized in connection with the Series C Preferred Stock was determined using the Monte Carlo simulation method.



All derivatives recognized by the Company are reported as derivative liabilities on the balance sheet and are adjusted to their fair value at each reporting date.  All gains and losses on derivative instruments are included in net gain (loss) on derivatives and convertible debt and with the exception of realized gains and losses related to the interest rate instruments, which are included in interest expense on the statements of operations. Net gains (losses) of $6,680,  $11,578, and ($14,430) were recognized related to derivative instruments for the years ended December, 2016, 2015, and 2014, respectively.



Recurring Fair Value Measurements



The following tables provide the fair value of the Company’s financial liabilities carried at fair value and measured on a recurring basis:







There were no transfers between levels during the years ended December 31, 2016, 2015, or 2014.





 

 

 

 

 

 

 

 

 

 

 

 



 

Fair value at

 

 

 

 

 

 

 

 

 



 

December 31, 2016

 

Level 1

 

Level 2

 

Level 3

Interest rate derivative

 

$

 

$

 -

 

$

 

$

 -

Convertible debt

 

 

1,315 

 

 

 -

 

 

 -

 

 

1,315 



 

$

1,323 

 

$

 -

 

$

 

$

1,315 







 

 

 

 

 

 

 

 

 

 

 

 



 

Fair value at

 

 

 

 

 

 

 

 

 



 

December 31, 2015

 

Level 1

 

Level 2

 

Level 3

Series C preferred embedded derivative

 

$

6,271 

 

$

 -

 

$

 -

 

$

6,271 

Warrant derivative

 

 

2,411 

 

 

 -

 

 

 -

 

 

2,411 

Interest rate derivatives

 

 

77 

 

 

 -

 

 

77 

 

 

 -



 

$

8,759 

 

$

 -

 

$

77 

 

$

8,682 



The following table presents a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis that use significant unobservable inputs (Level 3) and the related gains and losses recorded in the statement of operations during the periods:







 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Year ended December 31,



 

 

2016

 

2015



 

Series C Preferred embedded derivative

 

RES warrant derivative

 

Convertible debt

 

Total

 

Series C Preferred embedded derivative

 

RES warrant derivative

 

Total

Fair value, beginning of period

 

$

6,271 

 

$

2,411 

 

$

 -

 

$

8,682 

 

$

13,804 

 

$

6,533 

 

$

20,337 

Net (gains) losses recognized in earnings

 

 

(4,848)

 

 

(1,800)

 

 

303 

 

 

(6,345)

 

 

(7,533)

 

 

(4,122)

 

 

(11,655)

Purchase and issuances

 

 

 -

 

 

 -

 

 

1,012 

 

 

1,012 

 

 

 -

 

 

 -

 

 

 -

Sales and settlements

 

 

(1,423)

 

 

 -

 

 

 -

 

 

(1,423)

 

 

 -

 

 

 -

 

 

 -

Gross transfers into Level 3

 

 

 -

 

 

 -

 

 

 -

 

 

 -

 

 

 -

 

 

 -

 

 

 -

Gross transfers out of Level 3 (1)

 

 

 -

 

 

(611)

 

 

 -

 

 

(611)

 

 

 -

 

 

 -

 

 

 -

Fair value, end of period

 

$

 -

 

$

 -

 

$

1,315 

 

$

1,315 

 

$

6,271 

 

$

2,411 

 

$

8,682 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total unrealized (gains) losses during the period included in earnings related to instruments held at end of period

 

$

 -

 

$

 -

 

$

303 

 

$

303 

 

$

(7,533)

 

$

(4,122)

 

$

(11,655)



(1)

RES warrants were permanently reclassified to additional paid-in capital as discussed above



Fair Value of Debt



The Company estimates the fair value of its fixed rate debt by discounting the future cash flows of each instrument at estimated market rates or credit spreads consistent with the maturity of debt obligations with similar credit policies. Credit spreads take into consideration general market conditions and maturity. The inputs utilized in estimating the fair value of debt are classified in Level 2 of the fair value hierarchy. The carrying value, net of deferred financing costs, and estimated fair value of the Company’s debt, excluding convertible debt, which is presented in the balance sheet at fair value, is presented in the table below:





 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Carrying value at December 31,

 

Estimated fair value at December 31,



 

2016

 

2015

 

2016

 

2015



 

 

 

 

 

 

 

 

 

 

 

 

Held for use

 

$

56,775 

 

$

44,667 

 

$

57,456 

 

$

45,771 

Held for sale

 

 

5,945 

 

 

41,344 

 

 

6,433 

 

 

43,508 

Total

 

$

62,720 

 

$

86,011 

 

$

63,889 

 

$

89,279 



Impaired Hotel Properties



In the performance of impairment analysis for both held for sale and held for use properties, fair value is determined with the assistance of independent real estate brokers and through the use of revenue multiples based on the Company’s experience with hotel sales as well as available industry information.  For held for sale properties, estimated selling costs are based on our experience with similar asset sales.  These are considered Level 3 inputs.  All impairment in the table below related to held for use properties relates to impairments taken when those properties were previously held for sale or upon their reclassification to held for use. The amount of impairment and recovery of previously recorded impairment recognized in the years ended December 31, 2016, 2015, and 2014 is shown in the table below: 





 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



 

Year ended December 31,



 

2016

 

2015

 

2014



 

Number of hotels

 

Impairment (loss) recovery

 

Number of hotels

 

Impairment (loss) recovery

 

Number of hotels

 

Impairment (loss) recovery

Continuing Operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Held for sale hotels:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Impairment loss

 

 

$

(1,273)

 

 -

 

$

 -

 

 -

 

$

 -

Sold hotels:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Impairment loss

 

 

 

(204)

 

 

 

(3,914)

 

 

 

(1,388)

Recovery of impairment

 

 -

 

 

 -

 

 

 

85 

 

 

 

119 

Net impairment loss reported in continuing operations

 

 

$

(1,477)

 

 

$

(3,829)

 

 

$

(1,269)



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discontinued Operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sold hotels:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Impairment loss

 

 -

 

$

 -

 

 

$

(117)

 

 

$

(2,450)

Recovery of impairment

 

 -

 

 

 -

 

 

 

238 

 

 

 

798 

Net impairment loss reported in discontinued operations

 

 -

 

$

 -

 

 

$

121 

 

13 

 

$

(1,652)



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total net impairment:

 

 

$

(1,477)

 

11 

 

$

(3,708)

 

16 

 

$

(2,921)